The possible link between pioglitazone exposure and the risk of bladder cancer has been contentious for a number of years. ABCD has now responded to the recent BMJ paper on the use of pioglitazone and bladder cancer risk. The emergence of recent evidence provides reassurance when pioglitazone safety is considered and ABCD calls for NICE to review this evidence to inform their advice on bladder cancer risk. For the ABCD response see: HERE
Clinicians have always personalised patient management. There is a growing momentum to improve this further through the integration of genomic information into clinical care. This will incorporate powerful new tools through which clinicians can further tailor healthcare, improving disease prevention, prediction, diagnosis and treatment. See: HERE
It is about TIME we assess the work place well-being for the trainee registrars in our wonderful specialty i.e. Diabetes & Endocrinology. It is something not done before in our specialty in UK but American physicians do it on a yearly basis. It is an important aspect to identify in our training and it may help improve work related experience and the stressors faced by our StR. This survey is completely anonymous and it may have a significant impact on identifying work related well-being/burnout.
https://youtu.be/o6yiV0afaUc At the ABCD autumn meeting in Brighton, ABCD Chair, Rob Gregory gave a memorable “swan song” after dinner speech in which he read from "The diabetic life" by RD Lawrence, 12th edition reprint with "wartime supplement". Full footage of the speech has been published on the ABCD youtube channel as well as an alternative view in which the reading from RD Lawrence is highlighted. This was Rob Gregory's last meeting as Chair of the Association
Members working in England and Wales can now access the first report from the National Diabetes Audit for 2015-16. I encourage you to look at data for your own CCGs and trusts to see how you compare with your peers. These data are important as they populate the CCG IAF and are used to identify those CCGs who are outliers in the worst sense.
The Federation of Royal Colleges of Physicians of the United Kingdom has a new vacancy for an Endocrinology & Diabetes SCE Examining Board Member. The deadline for applications being Monday 13 March, 2017. For appointment overview and duties and responsibilities see “current vacancies” on the website HERE
2017 Clinical Excellence Awards - for ABCD members applying for National Awards. The 2017 round opens on Tuesday 28th February 2017 and closes at 17.00 on Tuesday 25th April 2017. As before, ABCD will provide support to members who wish to make a national application at all levels. Please see the following information: HERE
Applications are being taken for a project to improve access to medical technology, specifically insulin pump therapy for adults with T1DM. The project has been shortlisted for the Darzi Fellowship programme in Kent, Surrey and Sussex. Applications, closing date January 23, 2017, should use the form below – it is the third project on the list:
The project: HERE
We are inviting colleagues to submit entries to this competition to find the best joint pharmacy and diabetes team initiative to improve insulin and prescribing safety in hospital.
On 11/12/16, the Scottish Government announced an additional £10 million funding for Type 1 diabetes. The funding is to increase pump provision over the next 5 years and provide CGM to priority groups of patients including those with severe hypoglycaemia.
The Scottish Government has also published its draft budget for 2017-18. In this they commit to a new national outcome for type 2 diabetes and announce the intention to consult on a new strategy on diet and obesity.
